Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/10/23 → 11/04/24 |
Funding
- Celmatix Inc: £5,800.37
- Celmatix Inc: £74,511.63
AMH for chemoprotection in the human ovary
- Anderson, Richard (Principal Investigator)
- Rosario, Roseanne (Co-investigator)